Patents by Inventor Massimo Alfano

Massimo Alfano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND AGENTS MODULATING UPA/UPAR ACTIVITY
    Publication number: 20110027285
    Abstract: This invention herein disclosed relates to the anti-HIV action of uPAR-activators or activated uPAR molecules, the control of chemotaxis and cell migration by agents interfering with uPAR activation, a method for determining activated uPAR forms, the use of agents interfering with uPA/uPAR interaction for the diagnosis or therapy of diseases.
    Type: Application
    Filed: April 6, 2010
    Publication date: February 3, 2011
    Applicant: FONDAZIONE CENTRO SAN RAFFAELE MONTE TABOR
    Inventors: FRANCESCO BLASI, NICOLAI SIDENIUS, MASSIMO RESNATI, ANNA MONDINO, GUIDO POLI, MASSIMO ALFANO
  • Antibody against uPA/uPAR
    Patent number: 7737256
    Abstract: The invention herein disclosed relates to the anti-HIV action of uPAR-activators or activated uPAR molecules, the control of chemotaxis and cell migration by agents interfering with uPAR activation, a method for determining activated uPAR forms, the use of agents interfering with uPA/uPAR interaction for the diagnosis or therapy of diseases.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: June 15, 2010
    Assignee: Fondazione Centro San Raffaele Del Monte Tabor
    Inventors: Francesco Blasi, Nicolai Sidenius, Massimo Resnati, Anna Mondino, Guido Poli, Massimo Alfano
  • Methods and agents modulating upa/upar activity
    Publication number: 20040115190
    Abstract: The invention herein disclosed relates to the anti-HIV action of uPAR-activators or activated uPAR molecules, the control of chemotaxis and cell migration by agents interfering with uPAR activation, a method for determining activated uPAR forms, the use of agents interfering with uPA/uPAR interaction for the diagnosis or therapy of diseases.
    Type: Application
    Filed: January 29, 2004
    Publication date: June 17, 2004
    Inventors: Francesco Blasi, Nicolai Sidenius, Massimo Resnati, Anna Mondino, Guido Poli, Massimo Alfano
  • Anti-Viral Treatment With Pertussis Toxin B Oligomer
    Publication number: 20020172687
    Abstract: There is disclosed a method for anti-viral therapy, and for decreasing infectivity of viruses that use the chemokine CCR5 receptor as a co-receptor by treatment with the B. pertussis toxin (PTX) B oligomer, wherein the PTX B oligomer is composed of from two to ten subunits of PTX B oligomer selected from the group consisting of S2, S3, S4, S5, and combinations thereof.
    Type: Application
    Filed: January 31, 2000
    Publication date: November 21, 2002
    Inventors: MIchael Bukrinsky, Massimo Alfano
  • Anti-viral treatment with pertussis toxin B oligomer
    Patent number: 6019979
    Abstract: There is disclosed a method for anti-viral therapy treatment with the Pertussis toxin beta subunit oligomer, wherein the oligomer is composed of from two to ten subunits of PTX selected from the group consisting of S2, S3, S4, S5, and combinations thereof.
    Type: Grant
    Filed: August 15, 1997
    Date of Patent: February 1, 2000
    Assignee: The Picower Institute for Medical Research
    Inventors: Michael Bukrinsky, Massimo Alfano